Company intelligence / Profile preview

Precision Quantomics

Spokane, Washington, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Precision Quantomics provides validated, high-sensitivity quantitative proteomics services and kits, enabling improved IVIVE and PBPK modeling to support safer, more effective, and more inclusive drug development. Early commercial traction includes industry and academic clients, and NIH STTR-funded development of population-specific in vitro reagents for translational research addressing health disparities.[3][4][2][1]

Industry: Drug Discovery Services

Partnerships

Washington State University (NIH STTR collaboration)[3]

Beyond the preview

Go deeper on Precision Quantomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Precision Quantomics.

Explore the full profile